| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Compass Therapeutics, Inc.'s insiders have accumulated 22,500 shares worth roughly $21K on balance. In the past 30 days, 1 insider bought and 0 sold. Recent activity has leaned to the buy side.
The largest recent buyer is Lerner Neil (Chief Accounting Officer), now holding an estimated $386K in CMPX. A senior officer buying with their own money is generally read as a stronger signal than routine insider selling.
CMPX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.60M | $43.05M | - | |
| Other | 1.00M | - | - | |
| Other | 1.00M | - | - | |
| CFO | 670.0K | - | - | |
| Other | 420.0K | $386.4K | +20.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Lerner Neil | Chief Accounting Officer | Buy | 20,000 | $0.92 | $18,400.00 | +5.0% | - | - | |
| Sep 24, 2026 | Lerner Neil | Chief Accounting Officer | Buy | 2,500 | $1.14 | $2,850.00 | +0.6% | - | - | |
| May 27, 2025 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 10,000 | $2.11 | $21,100.00 | +0.2% | +43.1% | +7.6% | |
| Apr 9, 2025 | Orbimed Advisors LLC66 | Director, 10% Owner | Sell | 3,571,428 | $1.59 | $5,678,570.52 | -100% | +51.4% | +211.4% | |
| Apr 9, 2025 | Gordon Carl L74 | Director, 10% Owner | Sell | 3,571,428 | $1.59 | $5,678,570.52 | -100% | +51.4% | +211.4% | |
| Apr 7, 2025 | Anderman Jonathan | Gen Counsel &Corporate Sec | Buy | 20,000 | $1.54 | $30,800.00 | +2,000% | +68.2% | +238.2% | |
| Apr 7, 2025 | Lerner Neil | Chief Accounting Officer | Buy | 20,000 | $1.42 | $28,400.00 | +6.7% | +68.2% | +238.2% | |
| Mar 10, 2023 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 10,000 | $3.37 | $33,700.00 | +0.2% | -8.7% | -41.0% | |
| Feb 27, 2023 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,000 | $3.98 | $79,600.00 | +0.3% | -28.5% | -55.2% | |
| Feb 15, 2023 | Schuetz Thomas J.66 | Chief Executive Officer | Buy | 20,000 | $3.86 | $77,200.00 | +0.3% | -17.8% | -55.8% |